IL141496A0 - Phosphoglycolipid and methods for its use - Google Patents

Phosphoglycolipid and methods for its use

Info

Publication number
IL141496A0
IL141496A0 IL14149699A IL14149699A IL141496A0 IL 141496 A0 IL141496 A0 IL 141496A0 IL 14149699 A IL14149699 A IL 14149699A IL 14149699 A IL14149699 A IL 14149699A IL 141496 A0 IL141496 A0 IL 141496A0
Authority
IL
Israel
Prior art keywords
compound
phosphoglycolipid
methods
deoxy
ischemia
Prior art date
Application number
IL14149699A
Other languages
English (en)
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of IL141496A0 publication Critical patent/IL141496A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04—Phosphates; Phosphites; Polyphosphates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL14149699A 1998-08-21 1999-08-18 Phosphoglycolipid and methods for its use IL141496A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/138,305 US6013640A (en) 1998-08-21 1998-08-21 Phosphoglycolipid and methods for its use
PCT/US1999/019063 WO2000011010A1 (en) 1998-08-21 1999-08-18 Phosphoglycolipid and methods for its use

Publications (1)

Publication Number Publication Date
IL141496A0 true IL141496A0 (en) 2002-03-10

Family

ID=22481436

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14149699A IL141496A0 (en) 1998-08-21 1999-08-18 Phosphoglycolipid and methods for its use

Country Status (19)

Country Link
US (2) US6013640A (de)
EP (1) EP1105401B1 (de)
JP (1) JP2002523420A (de)
KR (1) KR20010072806A (de)
CN (1) CN1324364A (de)
AT (1) ATE263776T1 (de)
AU (1) AU754186B2 (de)
BR (1) BR9913175A (de)
CA (1) CA2340649A1 (de)
CZ (1) CZ2001637A3 (de)
DE (1) DE69916289D1 (de)
HU (1) HUP0103473A3 (de)
ID (1) ID28984A (de)
IL (1) IL141496A0 (de)
NO (1) NO20010854L (de)
NZ (1) NZ510260A (de)
PL (1) PL349422A1 (de)
TR (1) TR200100636T2 (de)
WO (1) WO2000011010A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699846B2 (en) * 2000-03-17 2004-03-02 Corixa Corporation Mono- and disaccharides for the treatment of nitric oxide related disorders
US20030139356A1 (en) * 2001-05-18 2003-07-24 Persing David H. Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
US20030105032A1 (en) * 2000-05-19 2003-06-05 Persing David H. Phophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds
EP2000144A1 (de) 2000-05-19 2008-12-10 Corixa Corporation Prophylaktische und therapeutische Behandlung von Infektions- und anderen Krankheiten mit Verbindungen auf Mono- und Di-Saccharid-Basis
US7129219B2 (en) * 2000-08-04 2006-10-31 Corixa Corporation Immunoeffector compounds
US7759803B2 (en) * 2001-07-25 2010-07-20 Rohm Co., Ltd. Semiconductor device and method of manufacturing the same
US7014991B2 (en) * 2001-11-16 2006-03-21 Infinite Vision, Llc Use of injectable dyes for staining an anterior lens capsule and vitreo-retinal interface
EP1482795B1 (de) * 2002-02-04 2009-11-11 Corixa Corporation Neue immuneffektor-verbindungen
US6911434B2 (en) 2002-02-04 2005-06-28 Corixa Corporation Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
RU2340621C2 (ru) 2002-07-08 2008-12-10 Корикса Корпорейшн Способы получения аминоалкилглюкозаминидфосфатов и дисахаридных иммуноэффекторов и их промежуточных соединений
US7288640B2 (en) * 2002-07-08 2007-10-30 Corixa Corporation Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor
WO2005042766A2 (en) * 2003-10-31 2005-05-12 Molecular Targeting Technologies, Inc. Technetium-99m glucarate methods of use for monitoring tissues
WO2006107107A1 (ja) * 2005-04-01 2006-10-12 Fumitaka Ohsuzu リン脂質小胞体を含む心筋保護剤および虚血・再潅流時の心筋障害を予防する方法
WO2008018932A2 (en) 2006-05-01 2008-02-14 The Board Of Trustees Of The Leland Stanford Junior University Method and use of nano-scale devices for reduction of tissue injury in ischemic and reperfusion injury
BRPI0721393B8 (pt) * 2007-03-22 2022-09-06 Fund Butantan método para obter lipídeo a monofosforilado da bordetella pertussis como um subproduto da produção de vacina celular contra coqueluche
BRPI0911195A2 (pt) * 2008-04-09 2017-06-20 The Univ Of North Caroline At Chapel Hill métodos de regulação de arranjo de citoesqueleto de actina e formação de gap intracelular
WO2026041647A1 (en) 2024-08-19 2026-02-26 Om Pharma Sa Small molecule targeting tlr4 overexpressing tumors and associated immunosuppressive, angiogenic and fibrotic complications

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5286718A (en) * 1991-12-31 1994-02-15 Ribi Immunochem Research, Inc. Method and composition for ameliorating tissue damage due to ischemia and reperfusion
WO1999020284A1 (en) * 1997-10-23 1999-04-29 Trustees Of The University Of Pennsylvania Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid a and adenosine receptor agents

Also Published As

Publication number Publication date
CZ2001637A3 (cs) 2001-10-17
WO2000011010A1 (en) 2000-03-02
NO20010854D0 (no) 2001-02-20
TR200100636T2 (tr) 2002-02-21
CA2340649A1 (en) 2000-03-02
CN1324364A (zh) 2001-11-28
ID28984A (id) 2001-07-19
PL349422A1 (en) 2002-07-29
NZ510260A (en) 2002-10-25
KR20010072806A (ko) 2001-07-31
NO20010854L (no) 2001-04-20
US6399590B2 (en) 2002-06-04
US6013640A (en) 2000-01-11
ATE263776T1 (de) 2004-04-15
JP2002523420A (ja) 2002-07-30
HUP0103473A3 (en) 2003-01-28
HUP0103473A2 (hu) 2002-04-29
DE69916289D1 (de) 2004-05-13
AU5683299A (en) 2000-03-14
AU754186B2 (en) 2002-11-07
EP1105401B1 (de) 2004-04-07
BR9913175A (pt) 2001-10-09
US20020013291A1 (en) 2002-01-31
EP1105401A1 (de) 2001-06-13

Similar Documents

Publication Publication Date Title
PL349422A1 (en) Phosphoglycolipid and methods for its use
CA2384504A1 (en) Use of retigabin for treating neuropathic pain
GR3034099T3 (en) Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
CA2261848A1 (en) Cell adhesion inhibitors
TW222584B (de)
IL142496A0 (en) N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
LV12731A (en) Flash-melt oral dosage formulation
WO1994008580A1 (en) Methods of combating pneumocystis carinii pneumonia and compounds useful therefor
PT928788E (pt) Compostos farmaceuticamente activos
ZA929709B (en) Method and composition for ameliorating tissue damage due to ischemia and reperfusion
UA41355C2 (uk) Засіб для лікування нейро-сніду
CA2266048A1 (en) Topical composition and method for enhancing lipid barrier synthesis
WO1999044623A8 (en) Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid
RU97104786A (ru) Раствор для защиты роговицы от повреждений "визиотон i"
CA2362833A1 (en) Phenylalaninol derivatives
AU1951499A (en) Use of mek1 inhibitors as protective agents against damage due to ischemia
GEP20043231B (en) Resorcinol Composition
RU93019277A (ru) Раствор для защиты и лечения заболеваний и повреждения роговицы "визитон"
NO970185D0 (no) Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi
WO2000002877A3 (en) New pharmaceutically active compounds
DK0613375T3 (da) Farmaceutiske lysinholdige polypeptidpræparater og anvendelse deraf
AU2149797A (en) Therapeutic agents for asthma
DE3569458D1 (en) Agent for the protection of and for combating damage caused to the vegetation
JPS5513285A (en) Imidazoline compound and medical composition
RU97104365A (ru) Бактерицидно-акарицидная мазь для лечения болезней кожи животных - "ям-бк"